The impact of age and gender on papillary thyroid cancer survival

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 6, 2012, Pages

  Jonklaas, Jacqueline ^a   Nogueras Gonzalez, G ^b   Munsell, M ^b   Litofsky, D ^b   Ain, K B ^c   Bigos, S T ^d,l   Brierley, J D ^e   Cooper, D S ^f   Haugen, B R ^g   Ladenson, P W ^f   Magner, J ^h   Robbins, J ⁱ   Ross, D S ^j   Skarulis, M C ⁱ   Steward, D L ^k   Maxon, H R ^k   Sherman, S I ^b  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

^d MAINE MEDICAL CENTER   (United States)

^e PRINCESS MARGARET HOSPITAL   (Canada)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF COLORADO   (United States)

^h GENZYME CORPORATION   (United States)

ⁱ NATIONAL INSTITUTES OF HEALTH   (United States)

^j MASSACHUSETTS GENERAL HOSPITAL   (United States)

^k UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^l PORTLAND VA MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

RADIOACTIVE IODINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CANCER MORTALITY; CANCER PATIENT; CANCER PROGNOSIS; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; MENOPAUSE; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; SEX DIFFERENCE; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY; UNITED STATES;

AGE DISTRIBUTION; AGED; CARCINOMA, PAPILLARY; COHORT STUDIES; CONTINENTAL POPULATION GROUPS; FEMALE; HUMANS; LONGEVITY; MALE; MENOPAUSE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REGISTRIES; SEX DISTRIBUTION; THYROID NEOPLASMS; UNITED STATES;

EID: 84861996314     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-2864     Document Type: Article

References (62)

1. Akslen LA, Haldorsen T, Thoresen SO, Glattre E 1991 Survival and causes of death in thyroid cancer: a population-based study of 2479 cases from Norway. Cancer Res 51:1234-1241
2. Cunningham MP, Duda RB, Recant W, Chmiel JS, Sylvester JA, Fremgen A 1990 Survival discriminants for differentiated thyroid cancer. Am J Surg 160:344-347
3. Micheli A, Ciampichini R, Oberaigner W, Ciccolallo L, de Vries E, Izarzugaza I, Zambon P, Gatta G, De Angelis R 2009 The advantage of women in cancer survival: an analysis of EUROCARE-4data. Eur J Cancer 45:1017-1027
4. Tubiana M, Schlumberger M, Rougier P, Laplanche A, Benhamou E, Gardet P, Caillou B, Travagli JP, Parmentier C 1985 Long-term results and prognostic factors in patients with differentiated thyroid carcinoma. Cancer 55:794-804 (Pubitemid 15173518)
5. Carcangiu ML, Zampi G, Pupi A, Castagnoli A, Rosai J 1985 Papillary carcinoma of the thyroid. A clinicopathologic study of 241 cases treated at the University of Florence, Italy. Cancer 55:805-828 (Pubitemid 15173519)
6. Elisei R, Molinaro E, Agate L, Bottici V, Masserini L, Ceccarelli C, Lippi F, Grasso L, Basolo F, Bevilacqua G, Miccoli P, Di Coscio G, Vitti P, Pacini F, Pinchera A 2010 Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question. J Clin Endocrinol Metab 95:1516-1527
7. Akslen LA, Myking AO, Salvesen H, Varhaug JE 1992 Prognostic importance of various clinicopathological features in papillary thyroid carcinoma. Eur J Cancer 29A:44-51
8. Mazzaferri EL, Jhiang SM 1994 Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97:418-428 (Pubitemid 24345593)
9. Samaan NA, Schultz PN, Hickey RC, Goepfert H, Haynie TP, Johnston DA, Ordonez NG 1992 The results of various modalities of treatment of well differentiated thyroid carcinomas: a retrospective review of 1599 patients. J Clin Endocrinol Metab 75:714-720
10. Mazzaferri EL, Kloos RT 2001 Clinical review 128: current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 86:1447-1463 (Pubitemid 32374886)
11. Shah JP, Loree TR, Dharker D, Strong EW, Begg C, Vlamis V 1992 Prognostic factors in differentiated carcinoma of the thyroid gland. Am J Surg 164:658-661
12. Mihailovic J, Stefanovic L, Malesevic M 2007 Differentiated thyroid carcinoma with distant metastases: probability of survival and its predicting factors. Cancer Biother Radiopharm 22:250-255 (Pubitemid 46988426)
13. Toniato A, Boschin I, Casara D, Mazzarotto R, Rubello D, Pelizzo M 2008 Papillary thyroid carcinoma: factors influencing recurrence and survival. Ann Surg Oncol 15:1518-1522
14. Bertakis KD, Azari R, Helms LJ, Callahan EJ, Robbins JA 2000 Gender differences in the utilization of health care services. J Fam Pract 49:147-152
15. Blom J, Yin L, Lidén A, Dolk A, Jeppsson B, Påhlman L, Holmberg L, Nyrén O 2008 Toward understanding nonparticipation in sigmoidoscopy screening for colorectal cancer. Int J Cancer 122:1618-1623 (Pubitemid 351294972)
16. Geiger TM, Miedema BW, Geana MV, Thaler K, Rangnekar NJ, Cameron GT 2008 Improving rates for screening colonoscopy: analysis of the health information national trends survey (HINTS I) data. Surg Endosc 22:527-533
17. Streetly A, Markowe H 1995 Changing trends in the epidemiology of malignant melanoma: gender differences and their implications for public health. Int J Epidemiol 24:897-907 (Pubitemid 26434114)
18. Oliveria SA, Christos PJ, Halpern AC, Fine JA, Barnhill RL, Berwick M 1999 Evaluation of factors associated with skin self-examination. Cancer Epidemiol Biomarkers Prev 8:971-978 (Pubitemid 29536089)
19. Machens A, Hauptmann S, Dralle H 2006 Disparities between male and female patients with thyroid cancers: sex difference or gender divide? Clin Endocrinol (Oxf) 65:500-505 (Pubitemid 44414274)
20. van der Schouw YT, van der Graaf Y, Steyerberg EW, Eijkemans JC, Banga JD 1996 Age at menopause as a risk factor for cardiovascular mortality. Lancet 347:714-718 (Pubitemid 26085645)
21. Weinstein M, Gorrindo T, Riley A, Mormino J, Niedfeldt J, Singer B, Rodríguez G, Simon J, Pincus S 2003 Timing of menopause and patterns of menstrual bleeding. Am J Epidemiol 158:782-791 (Pubitemid 37237242)
22. McKinlay SM, Brambilla DJ, Posner JG 1992 The normal menopause transition. Maturitas 14:103-115
23. 2003 United States life tables, 2003. www.cdc.gov/nchs/data/statab/lewk3 pdf. Accessed January 7, 2007
24. Sherman SI, Brierley JD, Sperling M, Ain KB, Bigos ST, Cooper DS, Haugen BR, Ho M, Klein I, Ladenson PW, Robbins J, Ross DS, Specker B, Taylor T, Maxon HR 3rd 1998 Prospective multicenter study of thyroid carcinoma treatment: initial analysis of staging and outcome. National Thyroid Cancer Treatment Cooperative Study Registry Group. Cancer 83:1012-1021 (Pubitemid 28401936)
25. Taylor T, Specker B, Robbins J, Sperling M, Ho M, Ain K, Bigos ST, Brierley J, Cooper D, Haugen B, Hay I, Hertzberg V, Klein I, Klein H, Ladenson P, Nishiyama R, Ross D, Sherman S, Maxon HR 1998 Outcomeafter treatment of high-risk papillary and non-Hurthle-cell follicular thyroid carcinoma. Ann Intern Med 129:622-627 (Pubitemid 28480817)
26. Cooper DS, Specker B, Ho M, Sperling M, Ladenson PW, Ross DS, Ain KB, Bigos ST, Brierley JD, Haugen BR, Klein I, Robbins J, Sherman SI, Taylor T, Maxon 3rd HR 1998 Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment Cooperative Registry. Thyroid 8:737-744 (Pubitemid 28535681)
27. Jonklaas J, Sarlis NJ, Litofsky D, Ain KB, Bigos ST, Brierley JD, Cooper DS, Haugen BR, Ladenson PW, Magner J, Robbins J, Ross DS, Skarulis M, Maxon HR, Sherman SI 2006 Outcomes of patients with differentiated thyroid carcinoma following initial therapy. Thyroid 16:1229-1242 (Pubitemid 46080167)
28. Cady B, Sedgwick CE, Meissner WA, Wool MS, Salzman FA, Werber J 1979 Risk factor analysis in differentiated thyroid cancer. Cancer 43:810-820 (Pubitemid 9163606)
29. Patsopoulos NA, Tatsioni A, Ioannidis JP 2007 Claims of sex differences: an empirical assessment in genetic associations. JAMA 298:880-893 (Pubitemid 47311294)
30. Engeland A, Tretli S, Akslen LA, Bjørge T 2006 Body size and thyroid cancer in two million Norwegian men and women. Br J Cancer 95:366-370 (Pubitemid 44187599)
31. Mack WJ, Preston-Martin S, Dal Maso L, Galanti R, Xiang M, Franceschi S, Hallquist A, Jin F, Kolonel L, La Vecchia C, Levi F, Linos A, Lund E, McTiernan A, Mabuchi K, Negri E, Wingren G, Ron E 2003 A pooled analysis of case-control studies of thyroid cancer: cigarette smoking and consumption of alcohol, coffee, and tea. Cancer Causes Control 14:773-785 (Pubitemid 37463891)
32. Ghori FY, Gutterman-Litofsky DR, Jamal A, Yeung SC, Arem R, Sherman SI 2002 Socioeconomic factors and the presentation, management, and outcome of patients with differentiated thyroid carcinoma. Thyroid 12:1009-1016 (Pubitemid 35407488)
33. Mack WJ, Preston-Martin S, Bernstein L, Qian D, Xiang M 1999 Reproductive and hormonal risk factors for thyroid cancer in Los Angeles County females. Cancer Epidemiol Biomarkers Prev 8:991-997 (Pubitemid 29536092)
34. Negri E, Dal Maso L, Ron E, La Vecchia C, Mark SD, Preston-Martin S, McTiernan A, Kolonel L, Yoshimoto Y, Jin F, Wingren G, Rosaria Galanti M, Hardell L, Glattre E, Lund E, Levi F, Linos D, Braga C, Franceschi S 1999 A pooled analysis of case-control studies of thyroid cancer. II. Menstrual and reproductive factors. Cancer Causes Control 10:143-155 (Pubitemid 29161106)
35. La Vecchia C, Ron E, Franceschi S, Dal Maso L, Mark SD, Chatenoud L, Braga C, Preston-Martin S, McTiernan A, Kolonel L, Mabuchi K, Jin F, Wingren G, Galanti MR, Hallquist A, Lund E, Levi F, Linos D, Negri E 1999 A pooled analysis of case-control studies of thyroid cancer. III. Oral contraceptives, menopausal replacement therapy and other female hormones. Cancer Causes Control 10:157-166 (Pubitemid 29161107)
36. Galanti MR, Lambe M, Ekbom A, Sparén P, Pettersson B 1995 Parity and risk of thyroid cancer: a nested case-control study of a nationwide Swedish cohort. Cancer Causes Control 6:37-44
37. Rossing MA, Voigt LF, Wicklund KG, Williams M, Daling JR 1998 Use of exogenous hormones and risk of papillary thyroid cancer (Washington, United States). Cancer Causes Control 9:341-349 (Pubitemid 28319026)
38. McTiernan AM, Weiss NS, Daling JR 1984 Incidence of thyroid cancer in women in relation to reproductive and hormonal factors. Am J Epidemiol 120:423-435 (Pubitemid 14032090)
39. Rajoria S, Suriano R, Shanmugam A, Wilson YL, Schantz SP, Geliebter J, Tiwari RK 2010 Metastatic phenotype is regulated by estrogen in thyroid cells. Thyroid 20:33-41
40. Parlea L, Fahim L, Munoz D, Hanna A, Anderson J, Cusimano M, Kovacs K, Gardiner G 2006 Follicular carcinoma of the thyroid with aggressive metastatic behavior in a pregnant woman: report of a case and review of the literature. Hormones (Athens) 5:295-302
41. Leboeuf R, Emerick LE, Martorella AJ, Tuttle RM 2007 Impact of pregnancy on serum thyroglobulin and detection of recurrent disease shortly after delivery in thyroid cancer survivors. Thyroid 17:543-547 (Pubitemid 47068117)
42. Yasmeen S, Cress R, Romano PS, Xing G, Berger-Chen S, Danielsen B, Smith LH 2005 Thyroid cancer in pregnancy. Int J Gynaecol Obstet 91:15-20 (Pubitemid 41278554)
43. Vannucchi G, Perrino M, Rossi S, Colombo C, Vicentini L, Dazzi D, Beck-Peccoz P, Fugazzola L 2010 Clinical and molecular features of differentiated thyroid cancer diagnosed during pregnancy. Eur J Endocrinol 162:145-151
44. Moosa M, Mazzaferri EL 1997 Outcome of differentiated thyroid cancer diagnosed in pregnant women. J Clin Endocrinol Metab 82:2862-2866 (Pubitemid 27385640)
45. Navarro Silvera SA, Miller AB, Rohan TE 2005 Risk factors for thyroid cancer: a prospective cohort study. Int J Cancer 116:433-438 (Pubitemid 40993341)
46. Truong T, Orsi L, Dubourdieu D, Rougier Y, Hemon D, Guénel P 2005 Role of goiter and of menstrual and reproductive factors in thyroid cancer: a population-based case-control study in New Caledonia (South Pacific), a very high incidence area. Am J Epidemiol 161:1056-1065 (Pubitemid 40734354)
47. Sakoda LC, Horn-Ross PL 2002 Reproductive and menstrual history and papillary thyroid cancer risk: the San Francisco Bay Area thyroid cancer study. Cancer Epidemiol Biomarkers Prev 11:51-57 (Pubitemid 34118313)
48. Rossing MA, Voigt LF, Wicklund KG, Daling JR 2000 Reproductive factors and risk of papillary thyroid cancer in women. Am J Epidemiol 151:765-772 (Pubitemid 30461140)
49. Levi F, Franceschi S, Gulie C, Negri E, La Vecchia C 1993 Female thyroid cancer: the role of reproductive and hormonal factors in Switzerland. Oncology 50:309-315 (Pubitemid 23193926)
50. Candanedo-Gonzalez FA, Gamboa-Dominguez A 2007 Postmenopause is associated with recurrence of differentiated papillary thyroid carcinoma. Med Hypotheses 69:209-213 (Pubitemid 46711075)
51. Sener SF, Winchester DJ, Winchester DP, Du H, Barrera E, Bilimoria M, Krantz S, Rabbitt S 2009 The effects of hormone replacement therapy on postmenopausal breast cancer biology and survival. Am J Surg 197:403-407
52. Lee ML, Chen GG, Vlantis AC, Tse GM, Leung BC, van Hasselt CA 2005 Induction of thyroid papillary carcinoma cell proliferation by estrogen is associated with an altered expression of Bcl-xL. Cancer J 11:113-121 (Pubitemid 44698822)
53. Kawabata W, Suzuki T, Moriya T, Fujimori K, Naganuma H, Inoue S, Kinouchi Y, Kameyama K, Takami H, Shimosegawa T, Sasano H 2003 Estrogen receptors (α and β) and 17β-hydroxysteroid dehydrogenase type 1 and 2 in thyroid disorders: possible in situ estrogen synthesis and actions. Mod Pathol 16:437-444 (Pubitemid 36618464)
54. Bonacci R, Pinchera A, Fierabracci P, Gigliotti A, Grasso L, Giani C 1996 Relevance of estrogen and progesterone receptors enzyme immunoassay in malignant, benign and surrounding normal thyroid tissue. J Endocrinol Invest 19:159-164 (Pubitemid 26162608)
55. Dalla Valle L, Ramina A, Vianello S, Fassina A, Belvedere P, Colombo L 1998 Potential for estrogen synthesis and action in human normal and neoplastic thyroid tissues. J Clin Endocrinol Metab 83:3702-3709 (Pubitemid 28500912)
56. Manole D, Schildknecht B, Gosnell B, Adams E, Derwahl M 2001 Estrogen promotes growth ofhumanthyroid tumor cells by different molecular mechanisms. J Clin Endocrinol Metab 86:1072-1077 (Pubitemid 32322984)
57. Chen GG, Vlantis AC, Zeng Q, van Hasselt CA 2008 Regulation of cell growth by estrogen signaling and potential targets in thyroid cancer. Curr Cancer Drug Targets 8:367-377
58. Byar DP, Green SB, Dor P, Williams ED, Colon J, van Gilse HA, Mayer M, Sylvester RJ, van Glabbeke M 1979 A prognostic index for thyroid carcinoma. A study of the E.O.R.T.C. Thyroid Cancer Cooperative Group. Eur J Cancer 15:1033-1041 (Pubitemid 9254743)
59. Brierley J, Tsang R, Panzarella T, Bana N 2005 Prognostic factors and the effect of treatment with radioactive iodine and external beam radiation on patients with differentiated thyroid cancer seen at a single institution over 40 years. Clin Endocrinol (Oxf) 63:418-427 (Pubitemid 41442336)
60. Greene F, Page, DL, Fleming, ID, eds. 2002 American Joint Committee on Cancer staging manual. New York: Springer-Verlag
61. Hay ID, Bergstralh EJ, Goellner JR, Ebersold JR, Grant CS 1993 Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 114:1050-1057; discussion 1057-1058
62. Cady B, Rossi R 1988 An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 104:947-953 (Pubitemid 19011971)